BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17112680)

  • 1. Human chorionic gonadotropin as an angiogenic factor in breast cancer during pregnancy.
    Michel RM; Aguilar JL; Arrieta O
    Med Hypotheses; 2007; 68(5):1035-40. PubMed ID: 17112680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
    Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCG in the regulation of placental angiogenesis. Results of an in vitro study.
    Herr F; Baal N; Reisinger K; Lorenz A; McKinnon T; Preissner KT; Zygmunt M
    Placenta; 2007 Apr; 28 Suppl A():S85-93. PubMed ID: 17382384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
    Hyder SM
    Endocr Relat Cancer; 2006 Sep; 13(3):667-87. PubMed ID: 16954424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
    Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
    J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
    Iovino F; Ferraraccio F; Orditura M; Antoniol G; Morgillo F; Cascone T; Diadema MR; Aurilio G; Santabarbara G; Ruggiero R; Belli C; Irlandese E; Fasano M; Ciardiello F; Procaccini E; Lo Schiavo F; Catalano G; De Vita F
    Cancer Invest; 2008; 26(3):250-5. PubMed ID: 18317965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does hCG or hCGβ play a role in cancer cell biology?
    Iles RK; Delves PJ; Butler SA
    Mol Cell Endocrinol; 2010 Nov; 329(1-2):62-70. PubMed ID: 20654692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chorionic gonadotropin (hCG) and prevention of breast cancer.
    Janssens JP; Russo J; Russo I; Michiels L; Donders G; Verjans M; Riphagen I; Van den Bossche T; Deleu M; Sieprath P
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):93-8. PubMed ID: 17386970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage.
    Schmidt M; Voelker HU; Kapp M; Dietl J; Kammerer U
    Anticancer Res; 2008; 28(3A):1719-24. PubMed ID: 18630531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gonadotropins: tissue-specific angiogenic factors?
    Reisinger K; Baal N; McKinnon T; Münstedt K; Zygmunt M
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):65-80. PubMed ID: 17349737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
    Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
    Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters.
    Cole LA; Butler SA
    J Reprod Med; 2008 Jul; 53(7):499-512. PubMed ID: 18720925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma.
    Cîmpean AM; Raica M; Suciu C; Tătucu D; Sârb S; Mureşan AM
    Rom J Morphol Embryol; 2008; 49(3):303-8. PubMed ID: 18758633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis, adipokines and breast cancer.
    Vona-Davis L; Rose DP
    Cytokine Growth Factor Rev; 2009 Jun; 20(3):193-201. PubMed ID: 19520599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential.
    Zhuang ZG; Di GH; Shen ZZ; Ding J; Shao ZM
    Mol Cancer Res; 2006 Nov; 4(11):843-9. PubMed ID: 17114342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vascular endothelial growth factor in breast cancer.
    Byrne GJ; McDowell G; Agarawal R; Sinha G; Kumar S; Bundred NJ
    Anticancer Res; 2007; 27(5B):3481-7. PubMed ID: 17972505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.